Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADC Therapeutics SA

1.82
-0.0200-1.09%
Volume:56.33K
Turnover:99.83K
Market Cap:175.98M
PE:-0.78
High:1.82
Open:1.80
Low:1.76
Close:1.84
Loading ...
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 19, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 05, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 28, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 17, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 21, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 16, 2023

Correspondence

Form CORRESP - Correspondence
Mar 15, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 02, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 02, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 23, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 09, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership